カテゴリ： 世界, 医療/バイオ, Market Monitor Global

TCR抗体のグローバル市場展望 2023年-2029年：NY-ESO-1、p53、WT-1、EBv、その他

■ 英語タイトル：TCR-Based Antibody Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8701）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8701
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[TCR抗体のグローバル市場展望 2023年-2029年：NY-ESO-1、p53、WT-1、EBv、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のTCR抗体市場規模と予測を収録しています。・世界のTCR抗体市場：売上、2018年-2023年、2024年-2029年
・世界のTCR抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のTCR抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「NY-ESO-1」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

TCR抗体のグローバル主要企業は、Adaptimmune Therapeutics、 Celgene、 Immunocore、 Kuur Therapeutics、 Lion TCR、 Kite Pharma、 Takara Bio、 Ziopharm Oncology、 GlaxoSmithKline、 Merck、 Juno Therapruticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、TCR抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のTCR抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界のTCR抗体市場：タイプ別市場シェア、2022年
・NY-ESO-1、p53、WT-1、EBv、その他

世界のTCR抗体市場：用途別、2018年-2023年、2024年-2029年
世界のTCR抗体市場：用途別市場シェア、2022年
・病院、専門クリニック、製薬・バイオテクノロジー研究所、遺伝子治療センター、その他

世界のTCR抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界のTCR抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるTCR抗体のグローバル売上、2018年-2023年
・主要企業におけるTCR抗体のグローバル売上シェア、2022年
・主要企業におけるTCR抗体のグローバル販売量、2018年-2023年
・主要企業におけるTCR抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Adaptimmune Therapeutics、 Celgene、 Immunocore、 Kuur Therapeutics、 Lion TCR、 Kite Pharma、 Takara Bio、 Ziopharm Oncology、 GlaxoSmithKline、 Merck、 Juno Theraprutics

*************************************************************

・調査・分析レポートの概要
TCR抗体市場の定義
市場セグメント
世界のTCR抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のTCR抗体市場規模
世界のTCR抗体市場規模：2022年 VS 2029年
世界のTCR抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのTCR抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のTCR抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：NY-ESO-1、p53、WT-1、EBv、その他
TCR抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門クリニック、製薬・バイオテクノロジー研究所、遺伝子治療センター、その他
TCR抗体の用途別グローバル売上・予測

・地域別市場分析
地域別TCR抗体市場規模 2022年と2029年
地域別TCR抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Adaptimmune Therapeutics、 Celgene、 Immunocore、 Kuur Therapeutics、 Lion TCR、 Kite Pharma、 Takara Bio、 Ziopharm Oncology、 GlaxoSmithKline、 Merck、 Juno Theraprutics
...

TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
This report aims to provide a comprehensive presentation of the global market for TCR-Based Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR-Based Antibody. This report contains market size and forecasts of TCR-Based Antibody in global, including the following market information:
Global TCR-Based Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global TCR-Based Antibody Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five TCR-Based Antibody companies in 2022 (%)
The global TCR-Based Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
NY-ESO-1 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of TCR-Based Antibody include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the TCR-Based Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global TCR-Based Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TCR-Based Antibody Market Segment Percentages, by Type, 2022 (%)
NY-ESO-1
p53
WT-1
EBv
Others
Global TCR-Based Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TCR-Based Antibody Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialized Clinics
Pharma and Biotech Research Laboratories.
Gene Therapy Centers
Others
Global TCR-Based Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TCR-Based Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies TCR-Based Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies TCR-Based Antibody revenues share in global market, 2022 (%)
Key companies TCR-Based Antibody sales in global market, 2018-2023 (Estimated), (K Units)
Key companies TCR-Based Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune Therapeutics
Celgene
Immunocore
Kuur Therapeutics
Lion TCR
Kite Pharma
Takara Bio
Ziopharm Oncology
GlaxoSmithKline
Merck
Juno Theraprutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of TCR-Based Antibody, market overview.
Chapter 2: Global TCR-Based Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of TCR-Based Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TCR-Based Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global TCR-Based Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 TCR-Based Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global TCR-Based Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global TCR-Based Antibody Overall Market Size
2.1 Global TCR-Based Antibody Market Size: 2022 VS 2029
2.2 Global TCR-Based Antibody Revenue, Prospects & Forecasts: 2018-2029
2.3 Global TCR-Based Antibody Sales: 2018-2029
3 Company Landscape
3.1 Top TCR-Based Antibody Players in Global Market
3.2 Top Global TCR-Based Antibody Companies Ranked by Revenue
3.3 Global TCR-Based Antibody Revenue by Companies
3.4 Global TCR-Based Antibody Sales by Companies
3.5 Global TCR-Based Antibody Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 TCR-Based Antibody Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers TCR-Based Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 TCR-Based Antibody Players in Global Market
3.8.1 List of Global Tier 1 TCR-Based Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 TCR-Based Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global TCR-Based Antibody Market Size Markets, 2022 & 2029
4.1.2 NY-ESO-1
4.1.3 p53
4.1.4 WT-1
4.1.5 EBv
4.1.6 Others
4.2 By Type – Global TCR-Based Antibody Revenue & Forecasts
4.2.1 By Type – Global TCR-Based Antibody Revenue, 2018-2023
4.2.2 By Type – Global TCR-Based Antibody Revenue, 2024-2029
4.2.3 By Type – Global TCR-Based Antibody Revenue Market Share, 2018-2029
4.3 By Type – Global TCR-Based Antibody Sales & Forecasts
4.3.1 By Type – Global TCR-Based Antibody Sales, 2018-2023
4.3.2 By Type – Global TCR-Based Antibody Sales, 2024-2029
4.3.3 By Type – Global TCR-Based Antibody Sales Market Share, 2018-2029
4.4 By Type – Global TCR-Based Antibody Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global TCR-Based Antibody Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialized Clinics
5.1.4 Pharma and Biotech Research Laboratories.
5.1.5 Gene Therapy Centers
5.1.6 Others
5.2 By Application – Global TCR-Based Antibody Revenue & Forecasts
5.2.1 By Application – Global TCR-Based Antibody Revenue, 2018-2023
5.2.2 By Application – Global TCR-Based Antibody Revenue, 2024-2029
5.2.3 By Application – Global TCR-Based Antibody Revenue Market Share, 2018-2029
5.3 By Application – Global TCR-Based Antibody Sales & Forecasts
5.3.1 By Application – Global TCR-Based Antibody Sales, 2018-2023
5.3.2 By Application – Global TCR-Based Antibody Sales, 2024-2029
5.3.3 By Application – Global TCR-Based Antibody Sales Market Share, 2018-2029
5.4 By Application – Global TCR-Based Antibody Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global TCR-Based Antibody Market Size, 2022 & 2029
6.2 By Region – Global TCR-Based Antibody Revenue & Forecasts
6.2.1 By Region – Global TCR-Based Antibody Revenue, 2018-2023
6.2.2 By Region – Global TCR-Based Antibody Revenue, 2024-2029
6.2.3 By Region – Global TCR-Based Antibody Revenue Market Share, 2018-2029
6.3 By Region – Global TCR-Based Antibody Sales & Forecasts
6.3.1 By Region – Global TCR-Based Antibody Sales, 2018-2023
6.3.2 By Region – Global TCR-Based Antibody Sales, 2024-2029
6.3.3 By Region – Global TCR-Based Antibody Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America TCR-Based Antibody Revenue, 2018-2029
6.4.2 By Country – North America TCR-Based Antibody Sales, 2018-2029
6.4.3 US TCR-Based Antibody Market Size, 2018-2029
6.4.4 Canada TCR-Based Antibody Market Size, 2018-2029
6.4.5 Mexico TCR-Based Antibody Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe TCR-Based Antibody Revenue, 2018-2029
6.5.2 By Country – Europe TCR-Based Antibody Sales, 2018-2029
6.5.3 Germany TCR-Based Antibody Market Size, 2018-2029
6.5.4 France TCR-Based Antibody Market Size, 2018-2029
6.5.5 U.K. TCR-Based Antibody Market Size, 2018-2029
6.5.6 Italy TCR-Based Antibody Market Size, 2018-2029
6.5.7 Russia TCR-Based Antibody Market Size, 2018-2029
6.5.8 Nordic Countries TCR-Based Antibody Market Size, 2018-2029
6.5.9 Benelux TCR-Based Antibody Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia TCR-Based Antibody Revenue, 2018-2029
6.6.2 By Region – Asia TCR-Based Antibody Sales, 2018-2029
6.6.3 China TCR-Based Antibody Market Size, 2018-2029
6.6.4 Japan TCR-Based Antibody Market Size, 2018-2029
6.6.5 South Korea TCR-Based Antibody Market Size, 2018-2029
6.6.6 Southeast Asia TCR-Based Antibody Market Size, 2018-2029
6.6.7 India TCR-Based Antibody Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America TCR-Based Antibody Revenue, 2018-2029
6.7.2 By Country – South America TCR-Based Antibody Sales, 2018-2029
6.7.3 Brazil TCR-Based Antibody Market Size, 2018-2029
6.7.4 Argentina TCR-Based Antibody Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa TCR-Based Antibody Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa TCR-Based Antibody Sales, 2018-2029
6.8.3 Turkey TCR-Based Antibody Market Size, 2018-2029
6.8.4 Israel TCR-Based Antibody Market Size, 2018-2029
6.8.5 Saudi Arabia TCR-Based Antibody Market Size, 2018-2029
6.8.6 UAE TCR-Based Antibody Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Adaptimmune Therapeutics
7.1.1 Adaptimmune Therapeutics Company Summary
7.1.2 Adaptimmune Therapeutics Business Overview
7.1.3 Adaptimmune Therapeutics TCR-Based Antibody Major Product Offerings
7.1.4 Adaptimmune Therapeutics TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.1.5 Adaptimmune Therapeutics Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene TCR-Based Antibody Major Product Offerings
7.2.4 Celgene TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Immunocore
7.3.1 Immunocore Company Summary
7.3.2 Immunocore Business Overview
7.3.3 Immunocore TCR-Based Antibody Major Product Offerings
7.3.4 Immunocore TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.3.5 Immunocore Key News & Latest Developments
7.4 Kuur Therapeutics
7.4.1 Kuur Therapeutics Company Summary
7.4.2 Kuur Therapeutics Business Overview
7.4.3 Kuur Therapeutics TCR-Based Antibody Major Product Offerings
7.4.4 Kuur Therapeutics TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.4.5 Kuur Therapeutics Key News & Latest Developments
7.5 Lion TCR
7.5.1 Lion TCR Company Summary
7.5.2 Lion TCR Business Overview
7.5.3 Lion TCR TCR-Based Antibody Major Product Offerings
7.5.4 Lion TCR TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.5.5 Lion TCR Key News & Latest Developments
7.6 Kite Pharma
7.6.1 Kite Pharma Company Summary
7.6.2 Kite Pharma Business Overview
7.6.3 Kite Pharma TCR-Based Antibody Major Product Offerings
7.6.4 Kite Pharma TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.6.5 Kite Pharma Key News & Latest Developments
7.7 Takara Bio
7.7.1 Takara Bio Company Summary
7.7.2 Takara Bio Business Overview
7.7.3 Takara Bio TCR-Based Antibody Major Product Offerings
7.7.4 Takara Bio TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.7.5 Takara Bio Key News & Latest Developments
7.8 Ziopharm Oncology
7.8.1 Ziopharm Oncology Company Summary
7.8.2 Ziopharm Oncology Business Overview
7.8.3 Ziopharm Oncology TCR-Based Antibody Major Product Offerings
7.8.4 Ziopharm Oncology TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.8.5 Ziopharm Oncology Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline TCR-Based Antibody Major Product Offerings
7.9.4 GlaxoSmithKline TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck TCR-Based Antibody Major Product Offerings
7.10.4 Merck TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Juno Theraprutics
7.11.1 Juno Theraprutics Company Summary
7.11.2 Juno Theraprutics TCR-Based Antibody Business Overview
7.11.3 Juno Theraprutics TCR-Based Antibody Major Product Offerings
7.11.4 Juno Theraprutics TCR-Based Antibody Sales and Revenue in Global (2018-2023)
7.11.5 Juno Theraprutics Key News & Latest Developments
8 Global TCR-Based Antibody Production Capacity, Analysis
8.1 Global TCR-Based Antibody Production Capacity, 2018-2029
8.2 TCR-Based Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global TCR-Based Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 TCR-Based Antibody Supply Chain Analysis
10.1 TCR-Based Antibody Industry Value Chain
10.2 TCR-Based Antibody Upstream Market
10.3 TCR-Based Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 TCR-Based Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • CAR T細胞ベース薬剤のグローバル市場展望 2023年-2029年：CD19標的、BCMA標的
  • ウサギモノクローナル抗体のグローバル市場展望 2023年-2029年：組織再編、非組換え
  • 抗イディオタイプ抗体作製サービスのグローバル市場展望 2023年-2029年：モノクローナル抗イディオタイプ抗体、ポリクローナル抗イディオタイプ抗体
  • CD161抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗CD3抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8701 )"TCR抗体のグローバル市場展望 2023年-2029年：NY-ESO-1、p53、WT-1、EBv、その他" (英文：TCR-Based Antibody Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。